Acute Lymphoblastic Leukemia — Trials

Acute Lymphoblastic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

2,037 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 546
Recruiting: 330
Ph III recruiting: 26
Growth YoY: −10%
Industry share: 13%
Top sponsor: City of Hope Medical Center
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (268)

clinicaltrialsPublishedShowing 51–100 of 732 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03876769	Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients(CASSIOPEIA)	active not recruiting	Phase 2	121	Novartis PharmaceuticalsINDUSTRY	11	Aug 19, 2026	clinicaltrials
NCT05082519	Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL(IDEAL2)	recruiting	Phase 2	240	Etan OrgelOTHER	1	Aug 19, 2026